Pictet Asset Management Sa Catalyst Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 12,538 shares of CPRX stock, worth $258,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,538
Previous 12,538
-0.0%
Holding current value
$258,282
Previous $207,000
18.84%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CPRX
# of Institutions
326Shares Held
94.6MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$166 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$128 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$117 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$62.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.12B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...